1 in 5 people being diagnosed with colorectal cancer are under age 55.

UVA Health’s Dr. Li Li weighs in on new research finding that colon cancer is the leading cause of cancer deaths in people under 50.

Colorectal cancer has long baffled scientists because, unlike most tumors, patients often do better when their cancers are ...

Meanwhile, mortality from other leading cancers is declining ...

Colorectal cancer has become the leading cause of cancer deaths for people under 50, rising from fifth place in the 1990s, ...

Moderate alcohol intake was linked to lower distal colon cancer risk. Lifetime drinking habits may significantly impact ...

Drinking alcohol is linked to higher chances of colorectal cancer − but just how many drinks increase your risk? Here's what ...

Colorectal cancer rates are rising rapidly among young people worldwide. | As colorectal cancer rises sharply among younger ...

New dietary research warns that your favorite comfort food could be compromising your digestive health if you're choosing the ...

“Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint ...

Zanzalintinib is an investigational oral agent that inhibits tyrosine kinase receptors associated with cancer growth, including TYRO3, VEGF, MET, AXL, and MER.

The U.S. FDA has granted fast track status to pelareorep combination therapy for some KRAS-mutant, microsatellite-stable metastatic colorectal cancers.